Molecular therapy for pulmonary arterial hypertension: USF1 (Upstream Transcription Factor 1) inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 9/June/2017, 11.58 pm
https://genomediscovery.org/wp-content/uploads/2017/06/USF1-inhibits-Notch3-and-Hes1-expression-and-attenuates-hypertension.jpg
960
720
Dr Boomi's Genom-2-Discovery Center
https://genomediscovery.org/wp-content/uploads/2017/06/USF1-inhibits-Notch3-and-Hes1-expression-and-attenuates-hypertension.jpg
What they say: A study from the University of California, La Jolla, California, USA shows that “Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published in the 15 November 2009 issue of the journal “Nature Medicine”[the number 1 journal in General…
read more